APA (7th ed.) Citation

SJ, T., JM, D., SA, D., EJ, D., CA, R., OM, D., . . . WY, L. (2017). Preventing chemotherapy-induced myelosuppression by repurposing the FLT3 inhibitor quizartinib. Science translational medicine, 9(402), . https://doi.org/10.1126/scitranslmed.aam8060

Chicago Style (17th ed.) Citation

SJ, Taylor, Duyvestyn JM, Dagger SA, Dishington EJ, Rinaldi CA, Dovey OM, Vassiliou GS, Grove CS, and Langdon WY. "Preventing Chemotherapy-induced Myelosuppression by Repurposing the FLT3 Inhibitor Quizartinib." Science Translational Medicine 9, no. 402 (2017). https://doi.org/10.1126/scitranslmed.aam8060.

MLA (9th ed.) Citation

SJ, Taylor, et al. "Preventing Chemotherapy-induced Myelosuppression by Repurposing the FLT3 Inhibitor Quizartinib." Science Translational Medicine, vol. 9, no. 402, 2017, https://doi.org/10.1126/scitranslmed.aam8060.